Cartesian Therapeutics
RNAC
$26.43
Share price
0.34%
Change (1 day)
2,281.08%
Change (1 year)
Categories
Revenue for Cartesian Therapeutics (RNAC)
Revenue in 2023 (TTM): $26 M
According to Cartesian Therapeutics's latest financial reports the company's current revenue (TTM
) is $26 M.
In 2022 the company made a revenue of $0.11 B an increase over the years 2021 revenue that were of $85.07 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cartesian Therapeutics from 2015 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $26 M | -76.53% |
| 2022 | $0.11 B | 30.21% |
| 2021 | $85.07 M | 412.6% |
| 2020 | $16.59 M | 148.57% |
| 2019 | $6.67 M | 639.42% |
| 2018 | $0.9 M | 336.23% |
| 2017 | $0.2 M | -97.44% |
| 2016 | $8.08 M | 34.47% |
| 2015 | $6.01 M |